[1]
Reshma Esmail & Udaya Manohar Kabadi 2021. The Improvement in Cardiovascular Risk Markers with Glimepiride in Pre-diabetic non-obese Subjects: Similar to Obese Cohort Treated with Metformin. Highlights on Medicine and Medical Research Vol. 5. (Apr. 2021), 123–128. DOI:https://doi.org/10.9734/bpi/hmmr/v5/2208E.